Ligand Reports Third Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Ligand Reports Third Quarter 2015 Financial Results

Ligand Pharma (LGND) Tops Q3 EPS by 14c

November 9, 2015 4:03 PM EST

Ligand Pharma (NASDAQ: LGND) reported Q3 EPS of $0.56, $0.14 better than the analyst estimate of $0.42. Revenue for the quarter came in at $17.7 million versus the consensus estimate of $17.8 million.

Release of Valuation Allowance

Ligand has accumulated a usable portfolio of net operating loss... More